Health
New evidence shows microbe strain can orally treat systemic inflammation in psoriasis – Science Codex
LUGANO, 29 October, 2020 – Disruptive innovations in psoriasis are leading the way at EADV’s 29th Congress, EADV Virtual. New data published today shows the first clinical evidence of modulating systemic inflammation by oral delivery of a non-living single strain commensal microbe. This new therapeutic class brings hope for a completely new way of treating this debilitating skin condition (1).
The phase 1b clinical study, by Evelo Biosciences, evaluated EDP1815, a preparation of a non-living single…
-
Business17 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News17 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business13 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News16 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses